You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA's Center for Drug Evaluation and Research Janet Woodcock, M.D., on the FDA's continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad

News provided by

U.S. Food and Drug Administration

Feb 22, 2019, 09:31 ET